OCUPHIRE PHARMA INC (OCUP) Stock Balance Sheet
NASDAQ:OCUP - Nasdaq - US67577R1023 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.41M | 50.50M | 42.63M | 24.53M | 16.40M | |||
| Marketable Securities | 5.00K | 15.00K | 50.00K | 220.00K | N/A | |||
| Receivables | 2.31M | 2.33M | 4.85M | N/A | N/A | |||
| Other Current Assets | 1.11M | 1.10M | 1.45M | 1.31M | 1.27M | |||
| Total Current Assets | 44.83M | 53.95M | 48.99M | 26.07M | 17.67M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 0.00 | 10.00K | 10.00K | 10.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 10.00K | 10.00K | |||
| TOTAL ASSETS | 44.83M | 53.95M | 48.99M | 26.08M | 17.68M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 540.00K | 0.00 | |||
| Accrued Expenses | 3.49M | 1.81M | 1.37M | 1.73M | 1.97M | |||
| Accounts Payable | 634.00K | 2.15M | 1.07M | 1.58M | 1.21M | |||
| Other Current Liabilities | 74.00K | 74.00K | 320.00K | N/A | 0.00 | |||
| Total Current Liabilities | 4.20M | 4.04M | 2.75M | 3.86M | 3.19M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | 0.00 | 0.00 | 27.96M | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 27.96M | |||
| TOTAL LIABILITIES | 4.20M | 4.04M | 2.75M | 3.86M | 31.15M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -96.34M | -81.47M | -71.48M | -89.37M | -32.68M | |||
| Additional Paid In Capital | 136.97M | 131.37M | 117.72M | 111.59M | 19.21M | |||
| Common Shares | 3.00K | 2.00K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 25.98M | 23.98M | 20.86M | 18.85M | 10.88M | |||
| Tangible Book Value per Share | 1.56 | 2.08 | 2.22 | 1.18 | -1.24 | |||
| Total Shareholders' Equity | 40.64M | 49.91M | 46.24M | 22.22M | -13.47M | |||
| TOTAL LIABILITIES AND EQUITY | 44.83M | 53.95M | 48.99M | 26.08M | 17.68M | |||
| Statistics | ||||||||
| Current Ratio | 10.68 | 13.35 | 17.81 | 6.75 | 5.54 | |||
| Return On Assets (ROA) | -31.46% | -18.51% | 36.52% | -217.37% | -139.25% | |||
| Return On Equity (ROE) | -34.71% | -20.01% | 38.69% | -255.13% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 31.15% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | 404.54% | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | 404.54% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21